Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
Rudek, Michelle A., Figg, William D., Dyer, Valerie, Dahut, William, Turner, Maria L., Steinberg, Seth M., Liewehr, David J., Kohler, David R., Pluda, James M., Reed, EddieVolume:
19
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2001.19.2.584
Date:
January, 2001
File:
PDF, 383 KB
english, 2001